Adipsin as a novel prognostic biomarker for cardiovascular diseases

被引：1

作者：

Askin, Lutfu ^{[1
]}

Askin, Husna Sengul ^{[2
]}

Abus, Sabri ^{[3
]}

Hidayet, Siho ^{[4
]}

机构：

[1] Adiyaman Educ & Res Hosp, Dept Cardiol, TR-2230 Adiyaman, Turkey

[2] Adiyaman Educ & Res Hosp, Dept Infect Dis, Adiyaman, Turkey

[3] Kahta State Hosp, Dept Cardiol, Adiyaman, Turkey

[4] Inonu Univ, Dept Cardiol, Med Fac, Malatya, Turkey

来源：

COR ET VASA | 2022年 / 64卷 / 01期

关键词：

Adipsin; Atherosclerosis; Cardiovascular disease; C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; PROMOTING INFLAMMATION; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; INSULIN-RESISTANCE; RISK-FACTORS; HYPERTENSION; ADIPONECTIN; CYCLOPHILIN;

D O I：

10.33678/cor.2021.086

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Increased vascular oxidative stress stimulates the secretion of adipokines from adipocytes. Many clinical studies have demonstrated that plasma adipsin levels are successful in predicting ischemic events. Increased adipsin levels are closely related to all-cause death and morbidity. Therefore, adipsin may be a new biomarker for atherosclerosis. In this review, we aimed to emphasize the association of adipsin with cardiovascular diseases (CVDs) and its beneficial role in the therapeutic field of CVDs.

引用

页码：34 / 37

页数：4